47 research outputs found
Development and validation of a clinical prediction rule for acute appendicitis in children in primary care
BACKGROUND: Recognising acute appendicitis in children presenting with acute abdominal pain in primary care is challenging. General practitioners (GPs) may benefit from a clinical prediction rule.OBJECTIVES: To develop and validate a clinical prediction rule for acute appendicitis in children presenting with acute abdominal pain in primary care.METHODS: In a historical cohort study data was retrieved from GP electronic health records included in the Integrated Primary Care Information database. We assigned children aged 4-18 years presenting with acute abdominal pain (≤ 7 days) to development (2010-2012) and validation (2013-2016) cohorts, using acute appendicitis within six weeks as the outcome. Multiple logistic regression was used to develop a prediction model based on predictors with > 50% data availability derived from existing rules for secondary care. We performed internal and external temporal validation and derived a point score to stratify risk of appendicitis into three groups, i.e. low-risk, medium-risk and high-risk.RESULTS: The development and validation cohorts included 2,041 and 3,650 children, of whom 95 (4.6%) and 195 (5.3%) had acute appendicitis. The model included male sex, pain duration (<24, 24-48, > 48 h), nausea/vomiting, elevated temperature (≥ 37.3 °C), abnormal bowel sounds, right lower quadrant tenderness, and peritoneal irritation. Internal and temporal validation showed good discrimination (C-statistics: 0.93 and 0.90, respectively) and excellent calibration. In the three groups, the risks of acute appendicitis were 0.5%, 7.5%, and 41%.CONCLUSION: Combined with further testing in the medium-risk group, the prediction rule could improve clinical decision making and outcomes.</p
Effectiveness of neuronavigation in resecting solitary intracerebral contrast-enhancing tumors:A randomized controlled trial
Object: The goal of this study was to assess the impact of neuronavigation on the cytoreductive treatment of solitary contrast-enhancing intracerebral tumors and outcomes of this treatment in cases in which neuronavigation was preoperatively judged to be redundant.Methods: The authors conducted a prospective randomized study in which 45 patients, each harboring a solitary contrast-enhancing intracerebral tumor, were randomized for surgery with or without neuronavigation. Peri- and postoperative parameters under investigation included the following: duration of the procedure; surgeon's estimate of the usefulness of neuronavigation; quantification of the extent of resection, determined using magnetic resonance imaging; and the postoperative course, as evaluated by neurological examinations, the patient's quality-of-life self-assessment, application of the Barthel index and the Karnofsky Performance Scale score, and the patient's time of death. The mean amount of residual tumor tissue was 28.9% for standard surgery (SS) and 13.8% for surgery involving neuronavigation (SN). The corresponding mean amounts of residual contrast-enhancing tumor tissue were 29.2 and 24.4%, respectively. These differences were not significant. Gross-total removal (GTR) was achieved in five patients who underwent SS and in three who underwent SN. Median survival was significantly shorter in the SN group (5.6 months compared with 9 months, unadjusted hazard ratio = 1.6); however, this difference may be attributable to the coincidental early death of three patients in the SN group. No discernible important effect on the patients' 3-month postoperative course was identified.Conclusions: There is no rationale for the routine use of neuronavigation to improve the extent of tumor resection and prognosis in patients harboring a solitary enhancing intracerebral lesion when neuronavigation is not already deemed advantageous because of the size or location of the lesion.</p
Estrogen receptor polymorphism predicts the onset of natural and surgical menopause
Age at menopause and risk of hysterectomy have strong genetic components, but the genes involved remain ill defined. We investigated whether genetic variation at the estrogen receptor (ER) gene contributes to the variability in the onset of menopause in 900 postmenopausal women, aged 55-80 yr, of the Rotterdam Study, a population-based cohort study in The Netherlands. Gynecological information was obtained, and if women reported surgical menopause, validation of type and indication of surgery was accomplished by checking medical records. The ER genotypes (PP, Pp, and pp) were assessed by PCR using the PvuII endonuclease. Compared with women carrying the pp genotype, homozygous PP women had a 1.1-yr (P < 0.02) earlier onset of menopause. Furthermore, an allele dose effect was observed, corresponding to a 0.5-yr (P < 0.02) earlier onset of menopause per copy of the P allele. The risk of surgical menopause was 2.4 (95% confidence interval, 1.5-3.8) times higher for women carrying the PP genotype compared to those in the pp group, with the most prominent effect in women who underwent hysterectomy due to fibroids or menorrhagia. We conclude that genetic variations of the ER gene are related to the onset of natural menopause and the risk of surgical menopause, especially hysterectomy.</p
Relation of alleles of the collagen type 1aplha1 gene to bone density and the risk of osteoporotic fractures in postmenopausal women
Vertebral deformities and functional impairment in men and women
Abstract
The objective of this study was to assess the prevalence and health effects of vertebral deformities i
Relation of alleles of the collagen type Ialpha1 gene to bone density and the risk of osteoporotic fractures in postmenopausal women
BACKGROUND: Osteoporosis is a common disorder with a strong genetic
component. One way in which the genetic component could be expressed is
through polymorphism of COLIA1, the gene for collagen type Ialpha1, a
bone-matrix protein. METHODS: We determined the COLIA1 genotypes SS, Ss,
and ss in a population-based sample of 177
Estrogen receptor polymorphism predicts the onset of natural and surgical menopause
Age at menopause and risk of hysterectomy have strong genetic components,
but the genes involved remain ill defined. We investigated whether genetic
variation at the estrogen receptor (ER) gene contributes to the
variability in the onset of menopause in 900 postmenopausal women, aged
55-80 yr, of the Rotterdam Study, a population-based cohort study in The
Netherlands. Gynecological information was obtained, and if women reported
surgical menopause, validation of type and indication of surgery was
accomplished by checking medical records. The ER genotypes (PP, Pp, and
pp) were assessed by PCR using the PvuII endonuclease. Compared with women
carrying the pp genotype, homozygous PP women had a 1.1-yr (P < 0.02)
earlier onset of menopause. Furthermore, an allele dose effect was
observed, corresponding to a 0.5-yr (P < 0.02) earlier onset of menopause
per copy of the P allele. The risk of surgical menopause was 2.4 (95%
confidence interval, 1.5-3.8) times higher for women carrying the PP
genotype compared to those in the pp group, with the most prominent effect
in women who underwent hysterectomy due to fibroids or menorrhagia. We
conclude that genetic variations of the ER gene are related to the onset
of natural menopause and the risk of surgical menopause, especially
hysterectomy
A polymorphism in the glucocorticoid receptor gene may be associated with and increased sensitivity to glucocorticoids in vivo
We investigated whether a polymorphism at nucleotide position 1220,
resulting in an asparagine-to-serine change at codon 363 in the
glucocorticoid receptor (GR) gene is associated with an altered
sensitivity to glucocorticoids. In a group of 216 elderly persons, 13
heterozygotes for the N363S polymorphism were identified by PCR/single
strand conformation polymorphism analysis. In 2 dexamethasone (DEX)
suppression tests (DSTs), using 1 and 0.25 mg DEX, the circulating
cortisol and insulin concentrations were compared between N363S carriers
and controls. In the 1-mg DST, there were no differences between N363S
carriers and controls, with respect to adrenal suppression, but there was
a significantly higher (P < 0.05) insulin response in N363S carriers. In
the 0.25-mg DST, a significantly larger (P < 0.05) cortisol suppression
and higher (P < 0.05) insulin response were seen in N363S carriers.
Comparison of blood pressure, body mass index (BMI), and bone mineral
density (BMD) between the N363S carriers and controls showed that N363S
carriers had a higher (P < 0.05) BMI but normal blood pressure. There was
an obvious trend towards lower age-, BMI-, and sex-adjusted BMD in the
lumbar spine in N363S carriers. GR characteristics measured in 41 controls
and 9 N363S carriers in peripheral mononuclear leucocytes showed no
differences between N363S carriers and controls, with respect to GR number
and ligand binding affinity. However, there was a trend towards greater
sensitivity to DEX in the carriers' lymphocytes, in a mitogen-induced cell
proliferation assay. In transfection assays, the capacity of the codon 363
variant to activate mouse mammary tumor virus promotor-mediated
transcription in COS-1 cells was unaltered, when compared with the
wild-type GR. We conclude that in 6.0% of our study population, a
polymorphism in codon 363 of the GR gene was found. Individuals carrying
this polymorphism seemed healthy at clinical examination but had a higher
sensitivity to exogenously administered glucocorticoids, with respect to
both cortisol suppression and insulin response. Life-long exposure to the
mutated allele may be accompanied by an increased BMI and a lowered BMD in
the lumbar spine but does not affect blood pressure
Relation of alleles of the collagen type 1aplha1 gene to bone density and the risk of osteoporotic fractures in postmenopausal women
Exercise therapy for Stress-related mental disorder, a randomised controlled trial in primary care
Background: to investigate whether a structured physical exercise programme (PEP) improves the recovery of general health in patients suffering from Stress-related Mental Disorder (SMD). Method: Study design: randomised open trial in general practice. Patients from two regions in the Netherlands were included between September 2003 and December 2005, and followed up for 12 weeks. Intervention: the patients were referred to a physical therapist for instruction in and monitoring of physical exercise of an intermediate intensity. Following the Dutch Guidelines for Healthy Physical Exercise, the patients were instructed to exercise at least five times a week, for at least 30 minutes per day. Control group: usual care from the GP Outcome: Primary: improvement of general health after 6 weeks according to the 'general health' dimension of the Short-Form 36. Secondary: total days off work, percentage that resumed work after 6 and 12 weeks, change in distress score and change in remaining SF36 dimensions after 6 and 12 weeks. Results: out of 102 randomised patients (mean age 43, 60 (59%) female), 70 (68%) completed the trial, of whom 31 were in the intervention group. After 6 weeks, the mean (SD) general health score was 54.6 (22.1) for the intervention group and 57.5 (19.2) for the controls. The corresponding effect size (Cohen's d with 95% confidence interval) from analysis of covariance was -0.06 (-0.41, 0.30) indicating no effect on general health. No significant effects of the intervention were detected for any secondary outcome parameter either. Conclusion: Notwithstanding the relatively high drop-out rate, our results suggest that referral to a physical therapist for structured physical exercise is not likely to be very effective in improving recovery from SMD. Trial registry: Current Controlled Trials ISRCTN15609105